THE DEVELOPMENT OF A POSTTRANSPLANT TLI TREATMENT STRATEGY THAT PROMOTES ORGAN ALLOGRAFT ACCEPTANCE WITHOUT CHRONIC IMMUNOSUPPRESSION>
INHIBITION OF HOST-VERSUS-GRAFT AND GRAFT-VERSUS-HOST RESPONSES AFTER SMALL BOWEL TRANSPLANTATION IN RATS BY RAPAMYCIN
INTESTINAL FUNCTION FOLLOWING ALLOGENEIC SMALL INTESTINAL TRANSPLANTATION IN THE RAT
EFFECTS OF COTRANSPLANTED FETAL LIVER ON FETAL PANCREAS ISOGRAFTS 1, 2.
LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS (WF RAT-B10 MOUSE) 1, 2
PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL IN RATS BY ANTI-TNF AND CYCLOSPORINE COMBINATION THERAPY
LIMITATIONS OF HEART PRESERVATION BY COLD STORAGE
REGULATION OF PULMONARY RESISTANCE DURING CARDIOPULMONARY PRESERVATION
THE EFFECT OF A NEW IMMUNOSUPPRESSIVE DRUG, BREQUINAR SODIUM, ON HEART, LIVER, AND KIDNEY ALLOGRAFT REJECTION IN THE RAT
BENEFICIAL EFFECTS OF CYCLOSPORINE ON POSTISCHEMIC LIVER INJURY IN RATS
DUODENAL MUCOSAL pH AS A REPERFUSION INDICATOR IN PANCREATIC-DUODENAL TRANSPLANTATION IN THE PIG
RENAL TRANSPLANT FUNCTION AFTER TEN YEARS OF CYCLOSPORINE
THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTS
RENAL ALLOGRAFT-INFIL TRATING LYMPHOCYTES A PROSPECTIVE ANALYSIS OF IN VITRO GROWTH CHARACTERISTICS AND CLINICAL RELEVANCE
ENISOPROST IN RENAL TRANSPLANTATION1
THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL TRANSPLANTATION1, 2
THE IMPACT OF HLA FREQUENCY DIFFERENCES IN RACES ON THE ACCESS TO OPTIMALLY HLA-MATCHED CADAVER RENAL TRANSPLANTS1
THE LARGE CENTER VARIATION IN HALF-LIVES OF KIDNEY TRANSPLANTS 1,2,3
THE EFFECT OF ERYTHROPOIETIN AND BLOOD TRANSFUSIONS ON HIGHLY SENSITIZED PATIENTS ON A SINGLE CADAVER RENAL ALLOGRAFT WAITING LIST1
CADAVERIC SMALL BOWEL AND SMALL BOWEL-LIVER TRANSPLANTATION IN HUMANS 1,2
LIVER TRANSPLANTATION FOR PRIMARY HEPATIC CANCER1
THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2
THE RESULTS OF REDUCED-SIZE LIVER TRANSPLANTATION, INCLUDING SPLIT LIVERS, IN PATIENTS WITH END-STAGE LIVER DISEASE 1
BILIARY COMPLICATIONS IN PEDIATRIC LIVER TRANSPLANTATION A COMPARISON OF REDUCED-SIZE AND WHOLE GRAFTS 1
HEPATIC ARTERY THROMBOSIS IN INFANTS A COMPARISON OF WHOLE LIVERS, REDUCED-SIZE GRAFTS, AND GRAFTS FROM LIVING-RELATED DONORS 1
THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2
HUMAN ISLET ISOLATION AND ALLOTRANSPLANTATION IN 22 CONSECUTIVE CASES 1, 2
A THREE-YEAR EXPERIENCE WITH SERUM ANODAL TRYPSINOGEN AS A BIOCHEMICAL MARKER FOR REJECTION IN PANCREATIC ALLOGRAFTS
WHENCE THE LUNGS? A STUDY TO ASSESS SUITABILITY OF DONOR LUNGS FOR TRANSPLANTATION 1
THE INDUCTION OF IMMUNOLOGIC HYPRESPONSIVENESS BY PREOPERATIVE DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS
RS-61443—A PHASE I CLINICAL TRIAL AND PILOT RESCUE STUDY 1
SOCIAL REHABILITATION AND RETURN TO WORK AFTER CARDIAC TRANSPLANTATION—A MULTICENTER SURVEY 1
SUCCESSFUL INDUCTION OF LONG-TERM SPECIFIC TOLERANCE TO FULLY ALLOGENEIC RENAL ALLOGRAFTS IN MINIATURE SWINE 1
HLA IN HUMAN SERUM—QUANTITATION OF CLASS I BY ENZYME IMMUNOASSAY 1
INTRAGRAFT CYTOKINE PROFILE DURING HUMAN LIVER ALLOGRAFT REJECTION 1, 2
ASSESSMENT OF THE IN VIVO IMMUNOSUPPRESSIVE ACTIVITY OF THE MAJOR CYCLOSPORINE METABOLITE BY LEUKEMIA ALLOGRAFT REJECTION 1, 2
THE EFFECT OF CYCLOSPORINE ADMINISTRATION ON THE CELLULAR DISTRIBUTION AND CONTENT OF CYCLOPHILIN 1
IMMUNOHEMOPOIETIC EFFECTS OF DIETARY NUCLEOTIDE RESTRICTION IN MICE 1, 2
SKIN XENOGRAFT REJECTION IN XENOPUS—IMMUNOHISTOLOGY AND EFFECT OF THYMECTOMY 1
ALLOGRAFT REJECTION IN CD4+ T CELL–RECONSTITUTED ATHYMIC NUDE RATS—THE NONESSENTIAL ROLE OF HOST-DERIVED CD8+ CELLS1
ADHESION MOLECULES ON HUMAN TONSIL DENDRITIC CELLS 1
COMPARISON OF UW AND EURO-COLLINS SOLUTIONS IN PAIRED CADAVERIC KIDNEYS
WHOLE-ORGAN TRANSPLANT OF AN ANNULAR PANCREAS
RECURRENT VARICEAL BLEEDING AFTER LIVER TRANSPLANTATION-PERSISTENT LEFT-SIDED PORTAL HYPERTENSION
INBIBITION OF LIVER, KIDNEY, AND INTESTINE REGENERATION BY RAPAMYCIN
A MAJOR DIFFERENCE IN THE MECHANISMS OF NEONATALLY INDUCED TOLERANCE AND CYCLOPHOSPHAMIDE-INDUCED TOLERANCE
A MAJOR DIFFERENCE IN THE MECHANISMS OF NEONATALLY INDUCED TOLERANCE AND CYCLOPHOSPHAMIDE-INDUCED TOLERANCE